Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Items 201–300 of 693
Changes in the central nervous system in diabetic neuropathy
Zang, Y., Jiang, D., Zhuang, X., & Chen, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18368 · Cited by 52
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02232-1 · Cited by 48
“Studies have identified age, diabetes duration, and glycosylated hemoglobin as risk factors for DPN progression [10, 11], and various other DPN-related factors are still being explored.”
BackgroundHoffman, W. H., Artlett, C. M., Zhang, W., Kreipke, C. W., Passmore, G. G., Rafols, J. A., & Sima, A. A. F. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.041 · Cited by 46
Hotaling, J. M., Sarma, A. V., Patel, D. P., Braffett, B. H., Cleary, P. A., Feldman, E. L., Herman, W. H., Martin, C. L., Jacobson, A. M., Wessells, H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0059 · Cited by 46
“high prevalence overall compared with reported prevalence rates of various forms of autonomic neuropathy in general in other cohorts of T1D and significantly higher compared with those without CAN (32).”
ResultChinese herbal medicine for diabetic peripheral neuropathy
Chen, W., Zhang, Y., Li, X., Yang, G., & Liu, J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007796.pub3 · Cited by 46
Vereșiu, I. A., Bondor, C. I., Florea, B., Vinik, E. J., Vinik, A. I., & Gavan, N. A. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.04.001 · Cited by 45
“In Romania, the data on the prevalence of diabetic neuropathy have been scarce (Cegedim, 2014; Cobuz & Cobuz, 2012; Tesfaye et al., 1996).”
BackgroundInfluentialThe risk factors for diabetic foot ulceration
Merza, Z., & Tesfaye, S. H. (2003) · The Foot · doi:10.1016/s0958-2592(03)00031-2 · Cited by 45
Self-citationOgbera, A. O., Adeleye, O., Solagberu, B. A., & Azenabor, A. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1423-2 · Cited by 49
Prevention and treatment of microvascular disease in childhood type 1 diabetes
Marcovecchio, M. L., Tossavainen, P. H., & Dunger, D. B. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldp053 · Cited by 51
TODAY Study Group, Katz, L. E. L., White, N. H., ghormli, L. K. E., Chan, C. L., Copeland, K. C., Lipman, T. H., Marcus, M. D., & Zeitler, P. S. (2021) · Diabetes Care · doi:10.2337/dc21-1074 · Cited by 45
May, O., Arildsen, H., Damsgaard, E. M., & Mickley, H. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00756.x · Cited by 44
Liu, F., Bao, Y., Hu, R., Zhang, X., Li, H., Zhu, D., Li, Y., Li, Y., Li, Y., Lu, J., et al. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1107 · Cited by 44
Haemodynamics in microvascular complications in type 1 diabetes
Candido, R., & Allen, T. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.313 · Cited by 46
“Significant trends of increasing prevalence of diabetic peripheral neuropathy were observed with diastolic blood pressure in the EURODIAB IDDM Complications Study [237].”
MethodStoian, A., Bănescu, C. V., Bălașa, R., Moțățăianu, A., Stoian, M., Moldovan, V. G., Voidăzan, S. T., & Dobreanu, M. (2015) · Disease Markers · doi:10.1155/2015/638693 · Cited by 44
“triglyceridemia, and presence of microalbuminuria [47], part of these observations being also confirmed by our study.”
ResultPatil, P. R., Wolfe, J., Said, Q., Thomas, J., & Martin, B. C. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000124 · Cited by 41
Kitamura, A., Taniguchi, Y., Seino, S., Yokoyama, Y., Amano, H., Fujiwara, Y., & Shinkai, S. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13637 · Cited by 42
Petrakis, I. E., & Sciacca, V. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.1999.1036 · Cited by 40
Epidemiology of diabetic retinopathy
Chew, E. Y. (2003) · Hospital Medicine · doi:10.12968/hosp.2003.64.7.2275 · Cited by 39
Hydrocolloid dressings for healing diabetic foot ulcers
Dumville, J. C., Deshpande, S., O’Meara, S., & Speak, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009099.pub2 · Cited by 48
Lower body mass index is not of more benefit for diabetic complications
Zhang, Y., Guo, Y., Shen, X., Zhao, F., & Yan, S. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13003 · Cited by 40
New Trends in the Etiopathogenesis of Diabetic Peripheral Neuropathy
Verrotti, A., Giuva, T., Morgese, G., & Chiarelli, F. (2001) · Journal of Child Neurology · doi:10.1177/088307380101600601 · Cited by 38
Kelle, B., Evran, M., Ballı, T., & Yavuz, F. (2016) · Journal of Back and Musculoskeletal Rehabilitation · doi:10.3233/bmr-160676 · Cited by 37
Clustering of microvascular complications in Type 1 diabetes mellitus
Bjerg, L., Hulmán, Á., Charles, M., Jørgensen, M. E., & Witte, D. R. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.01.011 · Cited by 45
Oh, T. J., Kang, S., Lee, J.-E., Moon, J. H., Choi, S. H., Lim, S. K., & Jang, H. C. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.04.007 · Cited by 38
BE SMART: Strategies for foot care and prevention of foot complications in patients with diabetes
Morey‐Vargas, O. L., & Smith, S. A. (2015) · Prosthetics and Orthotics International · doi:10.1177/0309364614535622 · Cited by 63
Swislocki, A., Orth, M., Bales, M., Weisshaupt, J., West, C. M., Edrington, J., Cooper, B. A., Saputo, L., Islas, M., & Miaskowski, C. A. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.05.021 · Cited by 37
Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus
Tentolouris, N., Pagoni, S., Τζώνου, Α., & Katsilambros, N. L. (2001) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(00)00128-x · Cited by 36
“A number of studies have shown that polyneuropathy, with a prevalence of 30–45% [1–3].”
BackgroundHajaš, G., Kissova, V., & Tirpáková, A. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12382 · Cited by 36
Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide
Sima, A. A. F. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.03.014 · Cited by 36
Tentolouris, A., Eleftheriadou, I., Grigoropoulou, P., Kokkinos, A. D., Siasos, G., Ntanasis‐Stathopoulos, I., & Tentolouris, N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.010 · Cited by 36
Benbow, S. J., & MacFarlane, I. A. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0021 · Cited by 35
Hempe, J., Elvert, R., Schmidts, H. ‐., Kramer, W., & Herling, A. W. (2011) · Laboratory Animals · doi:10.1258/la.2011.010165 · Cited by 35
Yun, J., Cha, S., Lim, T., Lee, E.-Y., Song, K., Ahn, Y., Yoo, K., Kim, J., Park, Y., & Ko, S. (2016) · Medicine · doi:10.1097/md.0000000000003128 · Cited by 35
“DPN was defined as the presence of 2 or more abnormalities according to typical symptoms, signs, quantitative sensory tests, or nerve conduction studies.(16)”
MethodDiabetic Neuropathy and Axon Reflex-Mediated Neurogenic Vasodilatation in Type 1 Diabetes
Nouri, M. N., Ahmed, A., Bril, V., Orszag, A., Ng, E., Nwe, P., & Perkins, B. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034807 · Cited by 35
“Diabetic sensorimotor polyneuropathy (DSP) – the most common complication in type 1 diabetes – represents diffuse symmetrical and length dependent injury to peripheral nerves and predisposes patients to neuropathic pain, sensory and motor dysfunction, and other complications[1–6].”
Fulk, G. D., Robinson, C. J., Mondal, S., Storey, C. M., & Hollister, A. M. (2010) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-7-44 · Cited by 40
“Only 30% of people with diabetes have peripheral neuropathy [11,12].”
BackgroundDIABETIC NEUROPATHY: DIAGNOSTIC METHODS —
Cornblath, D. R. (2004) · Advanced studies in medicine · Cited by 34
Nonproliferative Diabetic Retinopathy
MEYERLE, C. B., Chew, E. Y., & Ferris, F. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_1 · Cited by 37
SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status
de Preux, A.-S., Goosen, K., Zhang, W., Sima, A. A. F., Shimano, H., Ouwens, D. M., Diamant, M., Hillebrands, J., Rozing, J., Lemke, G., et al. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.04.010 · Cited by 35
“Abnormal lipid metabolism was previously proposed as one of the contributing factors in the pathogenesis of DPN (Coste et al., 2003; Horrobin, 1997).”
ResultInfluentialZhang, Y., Jiang, Y., Shen, X., & Yan, S. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2946-1 · Cited by 33
Oral dryness and peripheral neuropathy in subjects with type 2 diabetes
Sandberg, G. E., & Wikblad, K. F. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00220-9 · Cited by 33
Tao, M., McDowell, M., Saydah, S., & Eberhardt, M. S. (2007) · Diabetes Care · doi:10.2337/dc07-0931 · Cited by 34
Younis, B. B., Shahid, A., Arshad, R., Khurshid, S., & Masood, J. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0023-4 · Cited by 36
“6 % of the population studied in the current study, whereas 28 % of persons with neuropathy was reported in european diabetes centre study of complication [21] while a study reported 42.”
BackgroundVas, P. R. J., Green, A. Q., & Rayman, G. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2417-9 · Cited by 31
“It is known that age, sex and height have significant effects on the structure and function of large nerve fibres [16, 17].”
BackgroundOyibo, S. O., Breislin, K., & Boulton, A. J. M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01243.x · Cited by 32
Kempler, P., Tesfaye, S. H., Chaturvedi, N., Stevens, L. K., Webb, D. J., Eaton, S., Kerényi, Z., Tamás, G., Ward, J. D., & Fuller, J. (2001) · Archives of Physiology and Biochemistry · doi:10.1076/apab.109.3.215.11589 · Cited by 32
“Neuropathic symptoms and signs as well as vibration perception threshold were assessed (Tesfaye et al., 1996).”
BackgroundSelf-citationDanmusa, U. M., Terhile, I., & Nasir, I. A. (2016) · International Journal of Health Sciences · doi:10.12816/0048814 · Cited by 31
“(5) The lifetime risk persons with diabetes developing diabetes foot ulcers was reported to be as high as 25%.”
BackgroundDiabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 33
“The Pittsburg EDC study found smoking correlated with DN in participants with T1D ≥18 years,(34) and in EURODIAB, smoking was linked to cumulative DN incidence in T1D, independent of diabetes duration or HbA1c.(35) SEARCH similarly pointed to smoking as a DN risk factor in subjects with both T1D and T2D,(12) and a foc…”
BackgroundKasim, K., Amar, M. M., Sadek, A. A. E., & Gawad, S. A. (2009) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2009.10.002 · Cited by 31
Cheng, J., Daftari, A. P., & Zhou, L. (2012) · Case Reports in Anesthesiology · doi:10.1155/2012/285328 · Cited by 31
The Natural History of Charcot's Neuroarthropathy
Nielson, D. L., & Armstrong, D. G. (2008) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2007.10.004 · Cited by 32
Diabetic peripheral neuropathy: resource utilization and burden of illness
Mehra, M., Merchant, S., Gupta, S., & Potluri, R. C. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.928639 · Cited by 32
“Up to 50% of patients suffering from diabetes have peripheral neuropathy associated with the condition.(2-8) DPN affects the lower limbs first and then moves up to the upper limbs in a ‘stocking and glove’ pattern of distribution.”
BackgroundInsights into the pathogenesis and treatment of painful diabetic neuropathy
Greig, M., Tesfaye, S. H., Selvarajah, D., & Wilkinson, I. D. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00037-0 · Cited by 34
Self-citationYan, P., Zhang, Z., Miao, Y., Xu, Y., Zhu, J., & Wan, Q. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0498-7 · Cited by 32
“These findings were consistent with previous studies [2, 11, 27, 28], which imply a potential important role of metabolic and vascular disorder associated with atherosclerosis in the development of DPN.”
ResultPrevalence and determinants of diabetic polyneuropathy in a sub-Saharan African referral hospital
Kuate-Tegueu, C., Temfack, E., Ngankou, S., Doumbe, J. N., Djientcheu, V., & Kengne, A. P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.035 · Cited by 32
“in the UK [28] found a significant correlation between the presence of diabetic neuropathy and diabetes duration, the quality of blood sugar control, the height of the patients, the presence of proliferative diabetic retinopathy and smoking.”
BackgroundResultAlshammari, N. A., Alodhayani, A. A., Joy, S. S., Isnani, A. C., Mujammami, M. H., Alfadda, A. A., & Siddiqui, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s364933 · Cited by 33
Factors influencing nerve regeneration in a trial of timcodar dimesylate
Polydefkis, M. J., Sirdofsky, M., Hauer, P., Petty, B. G., Murinson, B. B., & McArthur, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000194209.37604.57 · Cited by 31
Abougalambou, S. S. I., & Abougalambou, A. S. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.09.002 · Cited by 32
Watanabe, K., Shimada, A., Miyaki, K., Hirakata, A., Matsuoka, K., Omae, K., & Takei, I. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/128726 · Cited by 30
Britten‐Jones, A. C., Silva, M. E. H. D., MacIsaac, R. J., Roberts, L. J., Kamel, J. T., Craig, J. P., Busija, L., & Downie, L. E. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz054 · Cited by 34
Benbow, S. J., Cossins, L., & MacFarlane, I. A. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00028.x · Cited by 33
Diabetic Peripheral Neuropathy
Pinzur, M. S. (2011) · Foot and Ankle Clinics · doi:10.1016/j.fcl.2011.01.002 · Cited by 29
A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy
Rutkove, S. B. (2009) · JAMA · doi:10.1001/jama.2009.1377 · Cited by 34
“The Europe and Diabetes Study (EURODIAB) found a prevalence of polyneuropathy of about 28% in 3250 randomly selected patients with insulin-dependent diabetes from across Europe.(9) Among individuals with diabetes in Olmstead County, Minnesota, 55% of those insulin dependent vs 54% of those noninsulin dependent had pol…”
InfluentialAslam, A., Singh, J., & Rajbhandari, S. M. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.12.007 · Cited by 29
Toward tailored disease management for type 2 diabetes.
Elissen, A., Duimel-Peeters, I. G. P., Spreeuwenberg, C., Spreeuwenberg, M. D., & Vrijhoef, H. J. (2012) · Research portal (Tilburg University) · Cited by 29
Electrocardiographic Left Ventricular Hypertrophy in Type 1 Diabetes
Giunti, S., Bruno, G., Veglio, M., Gruden, G., Webb, D. J., Livingstone, S. J., Chaturvedi, N., Fuller, J., Perin, P. C., & the EURODIAB IDDM Complications Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2255 · Cited by 28
Self-citationPharmacotherapy of painful diabetic neuropathy
Barbano, R. L., Hart-Gouleau, S., Pennella‐Vaughan, J., & Dworkin, R. H. (2003) · Current Pain and Headache Reports · doi:10.1007/s11916-003-0070-9 · Cited by 29
“The EURODIAB IDDM Complications Study [ 4 ] examined 3250 randomly selected patients with IDDM from 31 centers in 16 European countries.”
BackgroundHydrogel dressings for healing diabetic foot ulcers
Dumville, J. C., O’Meara, S., Deshpande, S., & Speak, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009101 · Cited by 35
Niu, Y., Li, J., Peng, R., Zhao, X., Wu, J., & Tang, Q. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3162 · Cited by 29
Leeds, J. S., Hadjivassiliou, M., Tesfaye, S. H., & Sanders, D. S. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000514 · Cited by 31
Self-citationAltschul, D., Starr, J. M., & Deary, I. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4645-8 · Cited by 27
Management of painful diabetic neuropathy
Tavakoli, M., & Malik, R. A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802498149 · Cited by 29
“4 Other interventions Angiotensin-converting enzyme inhibitors have been shown to have a protective effect against microvascular complications including nephropathy [18] and retinopathy [38].”
BackgroundFocal loss volume of ganglion cell complex in diabetic neuropathy
Srinivasan, S., Pritchard, N., Sampson, G. P., Edwards, K. P., Vagenas, D., Russell, A. W., Malik, R. A., & Efron, N. (2016) · Clinical and Experimental Optometry · doi:10.1111/cxo.12379 · Cited by 26
Lima, R. A. D. O., Piemonte, G. A., Nogueira, C. R., & Nogueira, V. D. S. N. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000337 · Cited by 26
“Many trials have evaluated the efficacy of exercise programs to prevent falls in older patients, and the Prevention of Falls Network Europe developed a taxonomy that classifies exercise modality as follows: (1) gait, balance, and functional training; (2) strength/ resistance training; (3) flexibility; (4) three-dimens…”
BackgroundHypertension the ‘Missed Modifiable Risk Factor’ for Diabetic Neuropathy: a Systematic Review
Sethi, Y., Uniyal, N., Vora, V., Agarwal, P., Murli, H., Joshi, A., Patel, N., Chopra, H., Hasabo, E. A., & Kaka, N. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101581 · Cited by 31
Animal Models of Diabetes-Induced Neuropathic Pain
Lee-Kubli, C. A., Mixcoatl-Zecuatl, T., Jolivalt, C. G., & Calcutt, N. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_280 · Cited by 29
Complications of type 1 diabetes: new molecular findings
Stirban, A. O., Rosen, P., & Tschoepe, D. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20057 · Cited by 29
A critical appraisal of erectile function in animal models of diabetes mellitus
Gür, S., Kadowitz, P. J., & Hellstrom, W. J. G. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00928.x · Cited by 29
Pambianco, G., Costacou, T., Strotmeyer, E. S., & Orchard, T. J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.005 · Cited by 27
“[5] Tesfaye S, Stevens L, Stephenson J, Fuller J, Plater M, Ionescu-Tirgoviste C, et al.”
Tactile directional sensibility and diabetic neuropathy
Norrsell, U., Eliasson, B., Frizell, M., Wallin, B. G., Wesslau, C., & Olausson, H. (2001) · Muscle & Nerve · doi:10.1002/mus.1174 · Cited by 31
“For example, early stages of diabetic neuropathy often require multiple diagnostic studies that can be both time-consuming and expensive.(3,6,8,33,36,37) Therefore, there is a need for predictive low-technology, i.”
BackgroundFerreira, J. S. S. P., Cruvinel-Júnior, R. H., Silva, E. Q., Veríssimo, J. L., Monteiro, R. L., Duarte, M., Giacomozzi, C., & Sacco, I. D. C. N. (2024) · Scientific Reports · doi:10.1038/s41598-024-78188-7 · Cited by 31
“The improvement in DPN symptoms for both groups at 24 weeks compared to baseline could be due to better glycemic control rather than the exercise program, as higher glycemic levels are linked to more severe DPN-related symptoms 48,49 .”
BackgroundGogan, A., Potre, O., Avram, V. F., Andor, M., Căruntu, F. R., & Timar, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030671 · Cited by 35
“The European Medicines Agency, Health Canada, and the U.S. FDA (Food and Drug Administration) have authorized pregabalin and duloxetine for the medical management of neuropathic pain in individuals with DM [18].”
Neuromuscular Complications of Diabetes Mellitus
Bril, V. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000450964.30710.a0 · Cited by 26
Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies
Arora, K., Tomar, P. C., & Mohan, V. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00830-2 · Cited by 31
Retinal Tissue Thickness is Reduced in Diabetic Peripheral Neuropathy
Srinivasan, S., Pritchard, N., Vagenas, D., Edwards, K. P., Sampson, G. P., Russell, A. W., Malik, R. A., & Efron, N. (2016) · Current Eye Research · doi:10.3109/02713683.2015.1119855 · Cited by 25
Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction
Wellmer, A., Sharief, M. K., Knowles, C. H., Misra, V. P., Kopelman, P., Ralph, D., & Anand, P. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00883.x · Cited by 27
Alginate dressings for healing diabetic foot ulcers
Dumville, J. C., O’Meara, S., Deshpande, S., & Speak, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009110.pub2 · Cited by 37
Sellman, A., Katzman, P., Andréasson, S., & Löndahl, M. (2018) · Diabetic Medicine · doi:10.1111/dme.13682 · Cited by 24
Kasznicki, J. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.42588 · Cited by 27
Müller-Stich, B. P., Billeter, A. T., Fleming, T. H., Fischer, L., Büchler, M. W., & Nawroth, P. P. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.007 · Cited by 25
“In insulin-dependent diabetic patients, the prevalence of diabetic neuropathy rises to about one third [2,3].”
BackgroundMen's Reproductive and Sexual Health
Forrest, K. A. (2001) · Journal of American College Health · doi:10.1080/07448480109596312 · Cited by 30
Padua, L., Saponara, C., Ghirlanda, G., Aprile, I. G., Padua, L., Pauri, F., & Tonali, P. (2001) · Neurological Sciences · doi:10.1007/s100720100020 · Cited by 24
“To evaluate the clinical-neurophysiological and metabolic assessment, a previously reported protocol was used [16].”
MethodRøikjer, J., Wegeberg, A., Nikontovic, A., Brock, C., & Vestergaard, P. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.08.006 · Cited by 27
Nelson, L. M., Tanner, C. M., Eeden, S. K. V. D., & McGuire, V. M. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133790.003.11 · Cited by 23
Al-Saoudi, E., Christensen, M. M. B., Nawroth, P. P., Fleming, T. H., Hommel, E. E., Jørgensen, M. E., Fleischer, J., & Hansen, C. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891442 · Cited by 28
Diabetes mellitus and apoptosis: inflammatory cells
Ryan, A., Murphy, M., Godson, C., & Hickey, F. B. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0340-z · Cited by 24
“In common with other microvascular complications of diabetes, the major risk factors are glycaemic control and duration of diabetes and there are no other treatments to slow the progression or delay the development of diabetic neuropathy [180].”
BackgroundEpidemiology and Health Care Cost of Diabetic Foot Problems
Cook, J. J., & Simonson, D. C. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-791-0_2 · Cited by 23
Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review
Ruiz‐Negrón, N., Menon, J., King, J. B., Ma, J., & Bellows, B. K. (2019) · PharmacoEconomics · doi:10.1007/s40273-018-00761-6 · Cited by 26
Andrei Cristian, B., & Popa, A. R. (2018) · Europe PMC (PubMed Central) · doi:10.26574/maedica.2018.13.3.229 · Cited by 22
Qiao, X., Zhang, S., Zhao, W., Ye, H., Yang, Y., Zhang, Z., Miao, Q., Hu, R., Li, Y., & Lü, B. (2015) · Medicine · doi:10.1097/md.0000000000001908 · Cited by 24
Autonomic Neuropathy: Diagnosis and Impact on Health in Adolescents with Diabetes
Donaghue, K. C. (1998) · Hormone Research in Paediatrics · doi:10.1159/000053100 · Cited by 22
“found in 43 IDDM patients the prevalence of symptoms was 12p and the prevalence of at least one of three abnormal cardiovascular tests was 24p.The EURODIAB IDDM Study examined prevalence of diabetic neuropathy in 3,250 randomly selected patients from 16 countries [”
Background
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.